NEVVI Medicare utilization intelligence

← back

Provider profile

BRONSNICK, TARA M.D.

Dermatology · NPI 1447678313 · LIVINGSTON, NJ

1
Groups
16
Codes · 2024
2,333
Disclosed services

BRONSNICK, TARA is a Dermatology in LIVINGSTON, NJ, a member of 1 medical group, who billed 16 distinct codes to Medicare Part B in 2024.

Groups: SUMMIT MEDICAL GROUP PA (BERKELEY HEIGHTS, NJ)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

2,333
disclosed services
16
codes billed to Medicare Part B
Prior year · CY2023 2,243 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
17003 Destruction of precancer skin growth, 2-14 growths premiumpremium premiumpremium
11102 Biopsy of related skin growth, first growth premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
17000 Destruction of precancer skin growth, 1 growth premiumpremium premiumpremium
17110 Destruction of skin growth, 1-14 growths premiumpremium premiumpremium
96900 Application of ultraviolet light to skin premiumpremium premiumpremium
96910 Therapy procedure using ultraviolet radiation with tar or petroleum jelly application premiumpremium premiumpremium
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more premiumpremium premiumpremium
11103 Biopsy of related skin growth, each additional growth premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
11900 Injection into skin growth, 1-7 growths premiumpremium premiumpremium
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more premiumpremium premiumpremium
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg premiumpremium premiumpremium
96567 Application of light to destroy precancer skin growth premiumpremium premiumpremium
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.